Who Should Obama Nominate for FDA Commissioner?
Survey began 11 November 2008
Survey ended 13 December 2008
See Resources & Further Reading below…
It seems like everyone in the Pharma Blogosphere and the press is recommending who president-elect Barack Obama should nominate — when he becomes president — as the new FDA Commissioner to replace Dr. Andrew von Eschenbach.
The following list presents the major contenders the pundits have identified with links to where you can find more information about them.
- Robert Califf, vice chancellor for clinical research and professor of medicine in the Division of Cardiology at Duke. More info…
- Dora Hughes, Health Policy Advisor to Senator Barack Obama. More info…
- David Kessler, former FDA Commissioner. More info…
- Steve Nissen, cardiologist at Cleveland Clinic. More info…
- Mary Pendergast, industry consultant who was a former associate FDA Commissioner under David Kessler. More info…
- Peter Rost, former Pfizer VP of Marketing, now a blogger. More info…
- Joshua Sharfstein, commissioner of the Baltimore City Health Department. More info…
- Mike Taylor, former Deputy FDA Commissioner under Clinton
- Susan Wood, the former head of women’s health at FDA, who resigned in protest after the delay in switching the morning-after pill over-the-counter. More info…
- Janet Woodcock, Center for Drug Evaluation & Research Director
- See the Pharma Marketing Surveys Forum and the post “SURVEY: Who Should be FDA Commissioner?” for news and opinions about who the new FDA commissioner should be.
Survey Results:
- Click here for a summary of survey results (interactive online version).
- Pharma Marketing News Summary: Reforming the FDA: It All Starts with a New Commissioner! (pdf)
